The sources said both deals could receive a green light from the Justice Department within the next few weeks.
To ease anticompetitive concerns, federal regulators will require CVS and Aetna to divest some of their Medicare Part D assets, the people familiar with the matter told WSJ. A potential bidder for the Part D assets is WellCare Health Plans, but conversations between CVS and Aetna are still ongoing, the sources said.
As for the Cigna-Express Scripts deal, people familiar with the transaction said it could gain approval without any divestitures, according to the report.
More articles on payers:
CMS erroneously sends termination letters to 38K+ BCBS Medicare members
Cigna hires global chief data and analytics officer
Medicaid covers 43% of childbirths
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.